BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.
Metrics to compare | 199730 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship199730PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | 16.2x | −0.4x | |
PEG Ratio | 0.02 | 0.05 | 0.00 | |
Price/Book | 1.2x | 1.5x | 2.6x | |
Price / LTM Sales | 0.9x | 2.8x | 3.2x | |
Upside (Analyst Target) | - | 45.0% | 49.0% | |
Fair Value Upside | Unlock | 5.1% | 6.8% | Unlock |